Concurrent chemoradiotherapy for locally advanced esophageal cancer - A pilot study by using daily low-dose cisplatin and continuous infusion of 5-fluorouracil

Anticancer Research

Volumn 19, Issue 5 C, 1999, Pages 4463-4467

  Hsu, Chih Hung ^a,b   Yeh, Kun Huei ^a,b   Lui, Louis Tak ^a   Lee, Yung Chie ^a   Bu, Ching Fang ^b   Wang, Hsiu Po ^a   Lin, Jaw Town ^a   Cheng, Ann Lii ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

5 fluorouracil; Chemoradiotherapy; Cisplatin; Esophageal cancer

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; CISPLATIN; FLUOROURACIL; PYRIMIDINE ANTAGONIST;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTINUOUS INFUSION; ESOPHAGUS CANCER; FEMALE; HUMAN; LEUKOPENIA; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; RADIATION-SENSITIZING AGENTS; SURVIVAL RATE;

EID: 0033427153     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Earlam R, Cunha-Melo J R: Oesophageal squamaus cell carcinoma. Br J Surg 67: 381-390 & 457-461, 1980.
2. Ilson DH, Kelsen DP: Combined modality therapy in the treatment of esophageal cancer. Semin Oncol 21(4): 493-507, 1994.
3. Flood WA, Forastiere M: Esophageal cancer. Curr Opinion Oncol 7: 381-386, 1995.
4. Forastiere M, Orringer MB, Perez-Tamayo C, Urba SG, Husted S, Takasugi BJ, Zahurak M: Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus. J Clin Oncol 8: 119-127, 1990 .
5. Forastiere M, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M: Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: Final report. J Clin Oncol 11: 1118-1123, 1993.
6. Le Prise E, Etienne PL, Meunier B, Maddern G, Ben Hassel M, Gedouin D, Boutin D, Campion JP, Launois B: A randomized study of chemotherapy, radiation therapy, and surgery versus surgery alone for localized squamous cell carcinoma of the esophagus. Cancer 73: 1779-1784, 1994.
7. Poplin E, Fleming T, Leichman L, Seydel HG, Steiger Z, Taylor S, Vance R, Stuckey WJ, Rivkin SE: Combined therapies for squamous-cell carcinoma of the esophagus, a Southwest Oncology Group Study (SWOG-8037). J Clin Oncol 5: 622-628,1990.
8. Seydel HG, Leichman L, Byhardt R, Cooper J, Herskovic A, Libnock J, Pazdur R, Speyer J, Tschan J, and the Radiation Therapy Oncology Group: Preoperative radiation and chemotherapy for localized squamous cell carcinoma of the esophagus - An RTOG study. Int J Radiat Oncol Biol Phys 14: 33-35,1988.
9. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE: Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 14: 156-163, 1996.
10. Stahl M, Wilke H, Fink U, Stuschke M, Walz MK, Siewert JR, Molls M, Fett W, Makoski H-B, Breuer N, Schmidt U, Niebel W, Sack H, Eigler FW, Seeber S: Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer: Interim analysis of a phase II trial. J Clin Oncol 14: 829-837, 1996.
11. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE: Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 70: 29-36,1991.
12. Herskovic A, Martz K, Al-Sarraf M, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L, Emami B: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593-1598, 1992.
13. Minsky BD, Neuberg D, Kelsen DP, Pisansky TM, Ginsberg R, Al Benson III: Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: A preliminary analysis of the phase II intergroup trial 0122. J Clin Oncol 14: 149-155, 1996.
14. Beahrs OG, Henson DE, Hutter RV, Kennedy BJ: Manual for staging of cancer. ed. 4, Philadelphia, JB Lippincott Company, 1992.
15. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-665, 1982.
16. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-481, 1958.
17. Dewit L: Combined treatment of radiation and cis-diamminedichloroplatinum (II): A review of experimental and clinical data. Int J Radiat Oncol Biol Phys 13: 403-426, 1987.
18. Rich TA, Lokich JJ, Chaffey JT: A pilot study of protracted venous infusion of 5-fluorouracil and concomitant radiation therapy. J Clin Oncol 3: 402-406, 1985.
19. Bartelink H, Kallman RF, Rapacchietta D, Hart GAM: Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum(II) and irradiation. Radiother Oncol 6: 61-74, 1986.
20. Lelieveld P, Scoles MA, Brown JM, Kallman RF: The effect of treatment in fractionated schedules with the combination X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin. Int J Radiat Oncol Biol Phys 11: 111-121, 1985.
21. Schaake-Koning C, van den Bogaert W, Dalesio O, Festen J, Hoogenhout J, van Houtte P, Kirkpatrick A, Koolen M, Maat B, Nijs A, Renaud A, Rodrigus P, Schuster-Uitterhoeve L, Sculier JP, van Zandwijk N, Bartelink H: Effects concomitant cisplatin and radiotherapy on inoperative non-small cell lung cancer. N Engl J Med 326: 524-530, 1992.
22. Schaake-Koning C, Matt B, van Houtte P, van den Bogaert W, Dalesio O, Kirkpatrick A, Bartelink H: Radiotherapy combined with low dose cis-diamminedichloroplatinum (II) (CDDP) in inoperable nonmetastatic non-small cell lung cancer (NSCLC): A randomized three arm phase II study of the EORTC lung cancer and radiotherapy cooperative groups. Int J Radiat Oncol Biol Phys 19: 967-972, 1990.
23. Lawrence TS, Tepper JE, Blackstock AW: Fluoropyrimidine-radiation interactions in cells and tumors. Semin Rad Oncol 7: 260-266, 1997.
24. O'Connell MJ, Martenson JA, Wieand HS, Krook JE, Macdonald JS, Haller DG, Mayer RJ, Gunderson LL, Rich TA: Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med. 331: 502-507, 1994.